12,000 koreans monitored for vaccine side effects over 6 years
NCT ID NCT05032976
First seen Nov 01, 2025 · Last updated Jun 10, 2026 · Updated 33 times
Summary
This study tracks the safety of the Pfizer COVID-19 vaccine (BNT162b2) in 12,000 Korean adults who received it as part of routine care. Researchers will record any side effects, including serious ones, for up to 28 days after each dose. The goal is to gather real-world safety data to ensure the vaccine remains safe for public use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pfizer
Seoul, South Korea
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.